The Oligonucleotide Synthesis Market faces challenges such as high production costs, complex synthesis procedures, and stringent regulatory requirements. Ensuring high purity and minimizing synthesis errors remain significant hurdles for manufacturers, especially when producing long oligonucleotides for advanced therapeutic applications. Despite these challenges, innovations in automated...